Lineage Cell Therapeutics, Inc. – Filings and Transcripts

NYSE American: LCTX
Share price (4/24/26): $1.55
Market cap (4/24/26): $386 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Shelf registration

Prospectus supplement for primary offering

Prospectus supplement

Registration of securities for employees

Prospectus supplement for primary offering

Ownership Filter

Samuel George A. III

News Filter

Other Events, Financial Statements or Exhibits

Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Notice of effectiveness

Scanned paper annual report submission

Scanned paper annual report submission